Balwani Shut Down $96M Investor's Due Diligence, Jury Told

By Bonnie Eslinger (May 18, 2022, 10:52 PM EDT) -- A hedge fund manager testified Wednesday in the fraud trial of former Theranos executive Ramesh "Sunny" Balwani that before his firm and its affiliates invested $96.1 million he tried to do thorough due diligence, but Balwani rejected his requests to speak with two of the company's notable business partners....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!